Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
AOD2-2. RNAi薬のATTRvアミロイドーシスへの治療効果判定に対するNfLの有用性
関島良樹, Emre Aldinc, Simina Ticau, Michael Polydefkis, Hans Nienhuis, Chafic Karam, Senda Ajroud-Driss, Marcia Waddington-Cruz, Jennifer Barnes, Paul Nioi
Published in 神経治療学 (20.10.2022)
Get full text
Published in 神経治療学 (20.10.2022)
Journal Article
Combinatorial screening for therapeutics in ATTRv amyloidosis identifies naphthoquinone analogues as TTR-selective amyloid disruptors
Sasaki, Ryoko, Suico, Mary Ann, Chosa, Keisuke, Teranishi, Yuriko, Sato, Takashi, Kagami, Asuka, Kotani, Shunsuke, Kato, Hikaru, Hitora, Yuki, Tsukamoto, Sachiko, Yamashita, Tomohiro, Yokoyama, Takeshi, Mizuguchi, Mineyuki, Kai, Hirofumi, Shuto, Tsuyoshi
Published in Journal of pharmacological sciences (01.01.2023)
Published in Journal of pharmacological sciences (01.01.2023)
Get full text
Journal Article
Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant
Yamada, Masahito, Usui, Yuta, Komatsu, Junji, Nakamura-Shindo, Keiko, Hamaguchi, Tsuyoshi, Yamaguchi, Hiroki, Nakano, Hiroto, Kanemoto, Mizuki, Shibata, Shutaro, Hikishima, Sadao, Taniguchi, Yu, Iwasa, Kazuo, Akagi, Akio, Sakai, Kenji, Hayashi, Koji, Nozaki, Ichiro, Ono, Kenjiro
Published in Internal Medicine (01.08.2022)
Published in Internal Medicine (01.08.2022)
Get full text
Journal Article